Sen. Amy Klobuchar On Medical School Alzheimer's Research: "Incredibly Impressive"

May 18, 2018

U.S. Senator Amy Klobuchar met April 6, 2018, with University of Minnesota Medical School Alzheimer’s researchers and saw first-hand some of the latest work being done for the disease. 5.7 million Americans are currently living with Alzheimer’s Disease. By 2050, that number is expected to rise to nearly 14 million people, according to the Alzheimer’s Association, with annual costs associated with the disease estimated to exceed $1 trillion at that time.

The senator met with UMN researchers, including Sylvain Lesné, PhD, an Associate Professor in the Department of Neuroscience. Lesné introduced the senator to some members of his group, including his laboratory manager, Mathew Sherman, and an undergraduate student, Damyan Hart.

 “I am proud of the state-of-the-art research studies on Alzheimer’s disease conducted at the University of Minnesota,” said Lesné. “My colleagues and I studying this disease have already seen that recent funding increases have accelerated research, and it is clear that a sustained investment in the future will be essential to continuing the momentum of research discoveries.”

Read more about Senator Klobuchar's visit.